Delivery Order HHSN261201500003I-HHSN26100042
Award Date
9/28/17
Potential Completion Date
6/30/27
Potential Value
$26M
Federal Agency
National Cancer Institute
Awardee
Leidos Biomedical Research Inc.
Ultimate Awardee
Leidos Holdings, Inc.
NAICS Category
561210 - Facilities Support Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,082,230.25 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for infrastructure improvements and supports the President's Department of Government Efficiency Cost Efficiency Initiative. The contract does not have a set-aside designation, indicating Leidos Biomedical Research Inc.'s competitive capabilities in providing comprehensive biomedical research...
This is a federal contract award by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $749,770.31 contract is a cost-plus-fixed-fee Delivery Order with a completion date of September 24, 2023 for work related to the BLDG. 1066 FIRST FLOOR REPOSITORY. Leidos Biomedical Research is a Federally Funded Research and Development Center (FFRDC) contractor for the National...
This is a $25,726,378.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health, to Leidos Biomedical Research Inc. The contract supports the implementation of the President's Department of Government Efficiency Cost Efficiency Initiative, with a period of performance through September 2029. The contract does not have a set-aside designation, indicating Leidos Biomedical Research's competitiveness in providing...
This is a $163,472,364.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract has an ultimate completion date of September 29, 2028 and does not utilize a set-aside designation. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing comprehensive biomedical research and facilities support services....
This is a $4,686,999.20 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is to support the President's Department of Government Efficiency Cost Efficiency Initiative through a Phase 1 trial, with a period of performance ending on July 6, 2026. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing...
This is a $401,797,653 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for operational task order work with an ultimate completion date of August 30, 2025. Leidos Biomedical Research Inc. is an experienced Federally Funded Research and Development Center (FFRDC) contractor for NCI, providing comprehensive biomedical research and facilities support services. The...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $22,388,857.00 contract is for the Proteomic Characterization Laboratory and supports the President's Department of Government Efficiency Cost Efficiency Initiative. The contract does not have a set-aside designation, indicating Leidos Biomedical...
This is a $2,528,739 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is part of the NCI's Cancer Data Ecosystem program and has an ultimate completion date of April 30, 2026. The contract does not have a set-aside designation. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing a wide range of...
The U.S. National Cancer Institute (NCI) awarded a Delivery Order worth $11,920,234.00 to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the ARPA-H BIOMEDICAL DATA FABRIC TOOLBOX PROGRAM, with an ultimate completion date of December 31, 2027. This award is part of Leidos Biomedical Research Inc.'s single-award Indefinite Delivery Contract with the NCI, valued at up to $6.6 billion over 5 years. The contract is a Cost Plus Fixed Fee arrangement and does...
This is a $15,990,578.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for coordinated facilities requirements and support services for the NCI through September 2030. This contract is not set aside for any specific business category. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing...